Aaron Royston
InvestorManaging Partner at venBio Partners
San Francisco Bay Area
Writes $20M β $30M checks Β· typically $25M
About
Aaron Royston, an MD and Wharton MBA with clinical research experience, was recognized as a White House Champion of Change and helped found and guide RayzeBio to IPO and acquisition.
Invests in
BiotechHealthtech
Experience
- venBio PartnersManaging Partnercurrent2015 β presentSan Francisco Bay Area
- Achieve Life SciencesBoard of Directorscurrent2026 β presentSan Francisco, California, United States
- Caldera TherapeuticsBoard of Directorscurrent2025 β presentBoston, Massachusetts, United States
- Marrow TherapeuticsBoard of Directorscurrent2024 β presentBoston, Massachusetts, United States
- Attovia TherapeuticsBoard of Directorscurrent2023 β presentSan Francisco Bay Area
- Candid TherapeuticsBoard of Directors2024 β 2026San Diego, California, United States
- 35PharmaBoard of Directors2022 β 2026Montreal, Quebec, Canada
- VicebioBoard of Directors2024 β 2025London Area, United Kingdom
- Ablaze PharmaceuticalsBoard of Directors2021 β 2025Shanghai, China
- RayzeBioBoard of Directors2020 β 2023San Diego, California, United States
- Ventyx BiosciencesBoard of Directors2021 β 2023San Diego, California, United States
- Harmony BiosciencesBoard Of Directors2017 β 2020Greater Philadelphia
- Akero TherapeuticsBoard Of Directors2018 β 2019San Francisco Bay Area
- Menlo Therapeutics Inc.Board Of Directors2017 β 2019San Francisco Bay Area
- Apellis PharmaceuticalsBoard of Directors2015 β 2017Louisville, Kentucky, United States
- Vivo CapitalSenior Associate2014 β 2015Palo Alto, CA
- Bain & CompanyConsultant2013 β 2014San Francisco Bay Area
- SportaneousFounder2010 β 2012
- The Mount Sinai HospitalClinical Research Coordinator2007 β 2008New York City
Education
- The Wharton SchoolMaster of Business Administration (M.B.A.), Health/Health Care Administration/Management
- University of PennsylvaniaDoctor of Medicine (M.D.)
- Duke UniversityB.S., Biological Sciences
- The Bishop's School
Skills & more
+4 more
Start-upsLife SciencesVenture CapitalStrategic PlanningFrom Aaron's professional profile.
Same school
Also attended The Wharton School1,323
+ 1,317 more
Also attended University of Pennsylvania607
+ 601 more
Also attended Duke University384
+ 378 more
Shared employers
Also worked at Achieve Life Sciences1
Also worked at Caldera Therapeutics1
Also worked at Candid Therapeutics1
Also worked at Harmony Biosciences1
Deals Β· 6
Marea Therapeutics, Inc.Board seat
via venBio Partners Β· filed Jun 2024 Β· $160.4M raise
Rayze BioBoard seat
via venBio Partners Β· filed Nov 2020 Β· $45M raise
Harmony BiosciencesBoard seat
via venBio Partners Β· filed Aug 2019 Β· $50M raise
Akero Therapeutics, Inc.Board seat
via venBio Partners Β· filed Dec 2018 Β· $45.5M raise
Menlo TherapeuticsBoard seat
via venBio Partners Β· filed Jul 2017 Β· $50.5M raise
Impel NeuropharmaBoard seat
via venBio Partners Β· filed Dec 2016 Β· $37.3M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at venBio Partners
Network4
Investors connected to Aaron in public investor directories β a warm-intro map.




.jpeg)





















